Cargando…
DKK1 as a robust predictor for adjuvant platinum chemotherapy benefit in resectable pStage II-III gastric cancer
BACKGROUND: Adjuvant chemotherapy (ACT) with 5-FU alone or 5-FU plus platinum after curative surgery improves the prognosis of pStage II-III gastric cancer (GC). However, only a subset of patients benefits from adjuvant platinum. To avoid the side effects of platinum, it is significant to accurately...
Autores principales: | Fan, Zhiyuan, Yu, Beiqin, Pan, Tao, Li, Fangyuan, Li, Jianfang, Hou, Junyi, Liu, Wentao, Su, Liping, Zhu, Zhenggang, Yan, Chao, Liu, Bingya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636483/ https://www.ncbi.nlm.nih.gov/pubmed/36332599 http://dx.doi.org/10.1016/j.tranon.2022.101577 |
Ejemplares similares
-
The dynamic alteration of transcriptional regulation by crucial TFs during tumorigenesis of gastric cancer
por: Yu, Beiqin, et al.
Publicado: (2022) -
Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data
por: Li, Fangyuan, et al.
Publicado: (2021) -
Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer
por: Li, Hao, et al.
Publicado: (2014) -
Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription
por: Pan, Tao, et al.
Publicado: (2021) -
microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer
por: Yu, Beiqin, et al.
Publicado: (2017)